Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Mouse V-set Domain Containing T-cell Activation Inhibitor 1 (VTCN1), C-Fc

Cat. No.AP2C903

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Mouse V-set Domain Containing T-cell Activation Inhibitor 1 (VTCN1), C-Fc is a recombinant protein expressed from Human Cells. Its predicted molecular weight is 30.9 kDa. The purity is>90%.

Specifications

Type Recombinant Protein
Species Mouse
Expression System Human Cells
Purity >90%
Endotoxin < 1.0 EU/μg
Predicted Molecular Weight 30.9 kDa
Physical State Lyophilized
Formulation 0.01 mol/L PBS (pH 7.2) containing 0.2% (w/v) Procline-300.

Target Information

Mouse V-set Domain Containing T-cell Activation Inhibitor 1 (VTCN1) is involved in immune regulation. It plays a role in inhibiting T cell activation, preventing excessive immune responses. VTCN1 has been implicated in autoimmune diseases, where its dysfunction may lead to uncontrolled immune activation. In immune regulation, VTCN1 may help maintain immune tolerance. This protein is a potential target for therapeutic intervention in autoimmune and inflammatory diseases.

Protein Mouse V-set Domain Containing T-cell Activation Inhibitor 1 (VTCN1)
Protein Synonym B7 homolog 4; Immune costimulatory protein B7-H4; Protein B7S1
Gene ID 242122
UniProt ID Q7TSP5

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket